A clinical study to evaluate the effectiveness of Sarvtobhadra vati in the patients of stage I, II and III of chronic renal failure.

J S Ayurveda Mahavidhyalaya0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Patients of stage I, II or III of chronic renal failure (eGFR not less than 30 ml/min/1.73m2).
•2.Patients having age between 18 to 65 years of both genders will be included for the study.
•3.Serum creatinine less than3.0 mg/dl.

•1.Patients who are on dialysis treatment. Patients who are already operated for renal transplantation and then having nephropathy.
•2.Patients of hepato-renal insufficiency or renal insufficiency due to haemodynemic circulatory disorders and CCF.
•3.Patients with some serious illness like cardio-vascular diseases, psychological disorders, serious acute organic diseases, serious chronic co-morbidities, liver disorders or metabolic disorders etc
•4.Female patients having pregnancy, breast feeding or post-delivery period.

发起方

J S Ayurveda Mahavidhyalaya